Lantern Pharma Inc.
(LTRN)
undefined
undefined%
At close: undefined
3.28
-5.34%
After-hours Dec 13, 2024, 04:53 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Revenue | - | - | - | - | - | - |
Cost of Revenue | 174.84K | 154.68K | 97.42K | 3.39K | 1.63K | -2.54K |
Gross Profit | -174.84K | -154.68K | -97.42K | -3.39K | -1.63K | 2.54K |
Operating Income | -17.88M | -14.43M | -12.59M | -5.91M | -2.43M | -1.73M |
Interest Income | 765.39K | 204.35K | 67.93K | - | - | - |
Pretax Income | -15.96M | -14.26M | -12.36M | -5.91M | -2.43M | -1.73M |
Net Income | -15.96M | -14.09M | -12.30M | -5.91M | -2.43M | -1.73M |
Selling & General & Admin | 5.98M | 5.83M | 5.02M | 3.66M | 1.48M | 1.15M |
Research & Development | 11.89M | 8.60M | 7.57M | 2.24M | 953.18K | 572.10K |
Other Expenses | - | -31.55K | 160.55K | - | - | - |
Operating Expenses | 17.88M | 14.43M | 12.59M | 5.91M | 2.43M | 1.73M |
Interest Expense | - | 204.35K | - | - | - | - |
Selling & Marketing Expenses | - | - | - | - | - | - |
Cost & Expenses | 17.88M | 14.43M | 12.59M | 5.91M | 2.43M | 1.73M |
Income Tax | - | -172.81K | -67.93K | -202.91K | -5 | 2.54K |
Shares Outstanding (Basic) | 10.84M | 10.85M | 10.90M | 6.22M | 6.27M | 6.22M |
Shares Outstanding (Diluted) | 10.84M | 10.85M | 10.90M | 6.22M | 6.27M | 6.22M |
EPS (Basic) | -1.47 | -1.3 | -1.13 | -0.95 | -0.39 | -0.28 |
EPS (Diluted) | -1.47 | -1.3 | -1.13 | -0.95 | -0.39 | -0.28 |
EBITDA | -15.79M | -14.42M | -12.27M | -5.90M | -2.43M | -1.73M |
Depreciation & Amortization | 174.84K | 154.68K | 97.42K | 3.39K | 1.63K | -2.54K |